Update on VTE, Supplement 3 December 2017
=========================================


In the article, [“Update on the management of venous thromboembolism” (Bartholomew JR, Cleve Clin J Med 2017; 84[Suppl 3]:39–46)](http://www.ccjm.org/lookup/doi/10.3949/ccjm.84.s3.04), 2 sentences in the text regarding dose reduction for body weight have errors. The corrected sentences follow:

On page 42, left column, the last 5 lines should read: “The recommended dose should be reduced to 2.5 mg twice daily in patients that meet 2 of the following criteria: age 80 or older; body weight of 60 kg or less; or with a serum creatinine 1.5 mg/dL or greater.”

And on page 42, right column, the sentence 10 lines from the top should read: “Edoxaban is given orally at 60 mg once daily but reduced to 30 mg once daily if the CrCL is 30 mL/min to 50 mL/min, if body weight is 60 kg or less, or with use of certain P-glyco-protein inhibitors.”

*   Copyright © 2018 The Cleveland Clinic Foundation. All Rights Reserved.